RENB
Price
$0.35
Change
-$0.01 (-2.78%)
Updated
Jun 26, 01:38 PM (EDT)
Capitalization
61.57M
XBIT
Price
$2.89
Change
+$0.23 (+8.65%)
Updated
Jun 26, 01:43 PM (EDT)
Capitalization
81.1M
50 days until earnings call
Interact to see
Advertisement

RENB vs XBIT

Header iconRENB vs XBIT Comparison
Open Charts RENB vs XBITBanner chart's image
Renovaro
Price$0.35
Change-$0.01 (-2.78%)
Volume$3.91K
Capitalization61.57M
XBiotech
Price$2.89
Change+$0.23 (+8.65%)
Volume$1.14K
Capitalization81.1M
RENB vs XBIT Comparison Chart in %
Loading...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RENB vs. XBIT commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RENB is a Hold and XBIT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (RENB: $0.36 vs. XBIT: $2.66)
Brand notoriety: RENB and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RENB: 21% vs. XBIT: 141%
Market capitalization -- RENB: $61.57M vs. XBIT: $81.1M
RENB [@Biotechnology] is valued at $61.57M. XBIT’s [@Biotechnology] market capitalization is $81.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RENB’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • RENB’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than RENB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RENB’s TA Score shows that 4 TA indicator(s) are bullish while XBIT’s TA Score has 4 bullish TA indicator(s).

  • RENB’s TA Score: 4 bullish, 3 bearish.
  • XBIT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RENB is a better buy in the short-term than XBIT.

Price Growth

RENB (@Biotechnology) experienced а +4.16% price change this week, while XBIT (@Biotechnology) price change was +2.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

RENB is expected to report earnings on May 15, 2025.

XBIT is expected to report earnings on Aug 15, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XBIT($81.1M) has a higher market cap than RENB($61.6M). XBIT YTD gains are higher at: -32.658 vs. RENB (-57.187). XBIT has higher annual earnings (EBITDA): -36.99M vs. RENB (-56.89M). XBIT has more cash in the bank: 156M vs. RENB (1.63M). RENB has less debt than XBIT: RENB (7.03M) vs XBIT (10M). RENB (0) and XBIT (0) have equivalent revenues.
RENBXBITRENB / XBIT
Capitalization61.6M81.1M76%
EBITDA-56.89M-36.99M154%
Gain YTD-57.187-32.658175%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.63M156M1%
Total Debt7.03M10M70%
FUNDAMENTALS RATINGS
RENB vs XBIT: Fundamental Ratings
RENB
XBIT
OUTLOOK RATING
1..100
159
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
6586
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XBIT's Valuation (74) in the Biotechnology industry is in the same range as RENB (98) in the Financial Conglomerates industry. This means that XBIT’s stock grew similarly to RENB’s over the last 12 months.

XBIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RENB (100) in the Financial Conglomerates industry. This means that XBIT’s stock grew similarly to RENB’s over the last 12 months.

XBIT's SMR Rating (94) in the Biotechnology industry is in the same range as RENB (97) in the Financial Conglomerates industry. This means that XBIT’s stock grew similarly to RENB’s over the last 12 months.

RENB's Price Growth Rating (65) in the Financial Conglomerates industry is in the same range as XBIT (86) in the Biotechnology industry. This means that RENB’s stock grew similarly to XBIT’s over the last 12 months.

XBIT's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for RENB (100) in the Financial Conglomerates industry. This means that XBIT’s stock grew significantly faster than RENB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RENBXBIT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 17 days ago
87%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMGAQ0.03N/A
+5.42%
Omega Therapeutics, Inc.
MURGF633.66-3.54
-0.55%
Muenchener Rueckver Ges
IMPUY8.68-0.14
-1.59%
Impala Platinum Holdings Ltd.
KAOOY8.87-0.20
-2.20%
Kao Corp.
FUUFF0.16-0.01
-3.50%
F3 URANIUM CORP. NEW

RENB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
+0.45%
VRCA - RENB
37%
Loosely correlated
+0.33%
DTIL - RENB
36%
Loosely correlated
-7.22%
TNGX - RENB
34%
Loosely correlated
-7.28%
XBIT - RENB
27%
Poorly correlated
-0.37%
AAVXF - RENB
26%
Poorly correlated
N/A
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with GLSI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then GLSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
-0.37%
GLSI - XBIT
42%
Loosely correlated
-0.55%
GBIO - XBIT
41%
Loosely correlated
-1.51%
NAUT - XBIT
40%
Loosely correlated
+10.50%
ABOS - XBIT
39%
Loosely correlated
-2.38%
TECH - XBIT
38%
Loosely correlated
+3.78%
More